After You Sign a PCD Franchise Agreement

You signed the agreement. Now what?

Most new franchise partners spend weeks preparing for the decision and almost no time preparing for what happens after it. That gap costs momentum. Servochem is a WHO-GMP certified PCD pharma franchise company in India, and here's exactly what separates a territory that gains traction fast from one that stalls in month one.

Finish Your Paperwork Before It Becomes a Bottleneck

Get your drug license and GST registration locked down immediately, ideally before you signed, not after. Delayed documentation causes most slow launches. Confirm your storage setup too. Pharmaceutical stock has real handling requirements, and scrambling to sort this out after your first order arrives wastes time you don't need to lose.

Order Lean, Not Broad

New partners want to launch with the full catalog. Resist that instinct. You don't yet know which formulations your local prescribers actually reach for. Order a focused starting selection from Servochem's ortho and pain management range, watch what moves, then expand based on real demand.

Pick Your First Ten Prescribers Carefully

Don't try to cover your entire territory in week one. Identify a small, genuinely relevant group of orthopedic specialists and general physicians who see real ortho and pain management volume. Build depth with them first.

What Territory Mapping Actually Looks Like in Practice

Before your first sales call, sit down with a real map, not a mental one, and mark every orthopedic clinic, physiotherapy center, and general practice within your assigned area. Rank them by likely patient volume. This takes an afternoon and saves weeks of unfocused driving around introducing yourself to whoever happens to be available.

Your Product Literature Does the Talking When You're Not There

Prescribers reference materials long after your conversation ends. Ready-made, accurate literature keeps products like Todoset 600 top of mind between visits. If a franchise partner has to write their own materials from scratch during an already busy launch period, that's a support gap worth flagging before signing.

Track Three Numbers, Not Twenty

Watch which formulations generate repeat interest. Watch which prescribers move from introduction to actual prescribing. Watch how your stock levels compare to real movement. These three signals tell you more in month one than total revenue ever will.

How to Know If Your Launch Is Actually on Track

By day thirty, you should have real conversations logged with your first ten prescribers, not just visits. By day sixty, at least a few of those conversations should have produced an actual prescription. By day ninety, you should see the first signs of a repeat order pattern forming. Don't wait for month four to ask why if none of these milestones are hit.

Budget for Month Three, Not Just Month One

The initial stock purchase gets all the attention during planning. Working capital for the months after gets ignored, and that's exactly when cash flow strain hits new partners hardest.

The Manufacturer Question Worth Asking Before You Sign Anything Else

Ask any prospective PCD partner one direct question: what happens on the exact day my first order ships? A manufacturer who can answer specifically, with real timelines and a real contact person, is telling you how the next ninety days will actually go. One who gives a vague answer is telling you something too.

Why Documentation Delays Cost More Than They Seem To

A drug license application that sits incomplete for two extra weeks doesn't just delay paperwork, it delays your first order, your first prescriber conversation, and your first real revenue.

Why Some Territories Outgrow Their Original Plan Entirely

A handful of partners start with a narrow category focus and end up representing Servochem's full ortho range within a year, simply because early success created room to expand. If your first few months go well, don't assume you have to stay locked into your original stock selection. That kind of deliberate growth, built on evidence from your own territory, tends to produce a more stable, higher-performing franchise business than expanding just because a new product launch happened to coincide with your timeline.

What Genuine Support Looks Like Once You're In

Orders processed without delay, especially in the early weeks when your credibility with prescribers is still being built
Literature ready on day one, not weeks into your launch
Direct access to someone who can answer formulation-specific questions
Straight answers about realistic timelines, not inflated promises

What to Do Right Now

If you're preparing to sign, ask your prospective manufacturer directly how they support this exact window. If you've already signed, start tracking your three numbers this week. Servochem operates as a PCD pharma franchise company in India built around exactly this transition, not just the sale that comes before it.